Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CHMP recommendation
Pharma
EU regulators endorse meds from BMS, J&J, Eisai and more
Over the course of the week, the European Medicines Agency’s CHMP signed off on four new drugs, as many biosimilars and 11 label expansions.
Fraiser Kansteiner
Nov 15, 2024 10:05am
Europe's CHMP backs Novo's FDA-rejected hemophilia treatment
Oct 18, 2024 11:27am
Apellis hit with yet another eye drug snub in Europe
Sep 20, 2024 10:06am
Europe's CHMP endorses clutch of new drugs at monthly meeting
Jul 26, 2024 9:59am
European regulators spurn Eisai and Biogen's Alzheimer's med
Jul 26, 2024 9:42am
CHMP rejects Apellis' Syfovre, says yes to Merck's Winrevair
Jun 28, 2024 11:59am
